| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |